PT  - JOURNAL ARTICLE
AU  - Park, Chihyun
AU  - Clemenceau, Jean R.
AU  - Seballos, Anna
AU  - Crawford, Sara
AU  - Lopez, Rocio
AU  - Coy, Tyler
AU  - Atluri, Gowtham
AU  - Hwang, Tae Hyun
TI  - Comprehensive Spatiotemporal Analysis of Opioid Poisoning Mortality in Ohio from 2010 to 2016
AID  - 10.1101/19005454
DP  - 2019 Jan 01
TA  - medRxiv
PG  - 19005454
4099  - http://medrxiv.org/content/early/2019/09/04/19005454.short
4100  - http://medrxiv.org/content/early/2019/09/04/19005454.full
AB  - Objective We aimed to identify (1) differences in opioid poisoning mortality among population groups, (2) geographic clusters of opioid-related deaths over time, and (3) health conditions co-occurring with opioid-related death in Ohio by computational analysis.Materials and Methods We used a large-scale Ohio vital statistic dataset from the Ohio Department of Health (ODH) and U.S. Census data from 2010-2016. We surveyed population differences with demographic profiling and use of relative proportions, conducted spatiotemporal pattern analysis with spatial autocorrelation via Moran statistics at the census tract level, and performed comorbidity analysis using frequent itemset mining and association rule mining.Results Our analyses found higher rates of opioid-related death in people aged 25-54, whites, and males. We also found that opioid-related deaths in Ohio became more spatially concentrated during 2010-2016, and tended to be most clustered around Cleveland, Columbus and Cincinnati. Drug abuse, anxiety and cardiovascular disease were found to predict opioid-related death.Discussion Comprehensive data-driven spatiotemporal analysis of opioid-related deaths provides essential identification of demographic, geographic and health factors related to opioid abuse. Future research should access personal health information for more detailed comorbidity analysis, as well as expand spatiotemporal models for real-time use.Conclusion Computational analyses revealed demographic differences in opioid poisoning, changing regional patterns of opioid-related deaths, and health conditions co-occurring with opioid overdose for Ohio from 2010-2016, providing essential knowledge for both government officials and caregivers to establish policies and strategies to best combat the opioid epidemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.Not ApplicableAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.Not ApplicableData was obtained from the publicly available U.S. Census datasets and American Community Survey. Mortality data was obtained from the Ohio Department of Health. Access and use was approved by the ODH IRB. https://www.census.gov/programs-surveys/acs/data.html